-(2-methyl-butyryloxy)-naphthalenl -yl]-heptanoic acid (5-lactone, respectively. The inhibitory effects of the two derivatives on the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase were similar to that of mevinolin.
Cardiovascular disease is one of the major causes of mortality in developed nations. There is convincing evidence that lowering plasma cholesterol levels reduces the risk of myocardial infarction2 '3) . The inhibition of the microsomal enzyme 3-hydroxy-3-methylgrutaryl-coenzyme A reductase (HMG-CoA reductase, EC 1. 1. 1.34), the rate-limiting enzyme in cholesterol biosynthesis, reduces the total cholesterol and decreases low density lipoprotein (LDL) level in animals as well as in human40. Mevinolin and related compounds (compactin, pravastatin and simvastatin) are competitive inhibitors of HMG-CoA reductase5~8).
In the present study, approximately 3000 strains of bacteria and fungi were screened for their ability for microbial conversion ofmevinolin. This work has shown that a fungal strain was able to convert mevinolin (1) to biotransformation products. Two conversion products were isolated from the fermentation broth of Absidia coerulea IDR 705 by extraction and chromatographic methods, and their structures were identified by UV, IR, XHNMR, 13C NMR and mass spectroscopy. As a result of structural analysis, compound 2 was found to be a new product in which the methyl group at 2-position was hydroxylated and one of the cyclohexene moieties was aromatized.
Materials and Methods

Microorganisms
Approximately 3000 strains selected from the strain collection of IDR (Institute for Drug Research Ltd., Budapest, Hungary) or isolated from soil samples SEPT. 1997 originating from different sources (Israel, NewZealand, Argentina) were screened. In this study Absidia coerulea determined with a JASCO J-720 spectropolarimeter. UV spectra were recorded on a Varian Cary 3E UV-VIS spectrophotometer in MeOH. IR spectra were recorded on a Bruker Vector-22 FT-IR spectrometer in film. NMR spectra were measured on a Bruker AC-250and a Bruker DRX-400spectrometer, respectively. Mass spectra were taken on a Finnigan MAT8430 instrument under the following conditions: resolution 1250, ion acceleration voltage 3kV, ion source temperature 250°C, El Ee= 70eV, Ic=0.5mA, evaporation temperatures 90°C (2) and 130°C (3), CI reagent gas /-butane, evaporation temperature 80°C. High resolution mass measurements were made at R = 10000, using perflourokerosene (PFK) as the reference standard.
Biological Assay HMG-CoA reductase inhibitory effect was determined by Panlabs Inc. Pharmacology Services using rat liver enzyme 1 4).
Results
The preliminary screening revealed that some fungal species transformed 1 into knowncompoundsand one 751 fungus strain A. coerulea IDR 705 generated two hydroxylated derivatives 2 and 3, besides some known compounds {e.g. monacolin J). The pooled fermented broths (1.0 litre) were adjusted to pH 3.0 with 1 n H2SO4 and then extracted three times with 300ml of EtOAc. The extract was washed with a 5% aqueous NaHCO3, dried over anhydrous Na2SO4 and evaporated under reduced pressure to dryness. The residue (0.8g compound 3 were recorded in CDC13using a Bruker AC-250 NMRspectrometer. In addition, 1H, 13C, DEPT 135 spectra and a TOCSY spectrum with a short mixing time (quasi COSY) of compound 3 in MeOH-d4 solution were measured on a Bruker DRX-400spectrometerÂ full assignment of the *H and 13C NMRspectra of compounds 2 and 3-based on the above measurements and the literature12'13)-is given in Tables 1 and 2 . The configuration of C-3 and C-5 chirality centers of compound3 were determined using NOE difference spectra. Upon saturation of H-3 signal (3.85ppm) intensity enhancement (4.7 and 1.3%, respectively) was observed on the H-2 and 2-Me signals, indicating that the relative configuration of the 2-Meand 3-OHgroups is trans. Upon saturation of H-5 signal (3.92ppm) intensity enhancement (6.1 and 1.1%, respectively)
occured on H-6 and 6-Me signals, indicating that the relative configuration of 5-OH and 6-Me groups is also trans. The absolute configurations of the chirality centers of mevinolin are knownand the change of these configurations is not probable upon microbial transformation.
According to these spectroscopic data, the structures of 2 and 3 were identified with j8, (5-dihydroxy-7-(l,2- dihydro-2-hydroxymethyl-6-methyl-naphthalenlyl)-heptanoic acid (5-lactone and jS,(5-dihydroxy-7-[l , 2, 3, 5, 6, 7, 8, 8a-octahydro-3, 5-dihydroxy-2, 6- 
The inhibitory effects of the derivatives 2 and 3 on HMG-CoAreductase are shown in Table 3 . The biological activities of the two new compoundsare similar to that of mevinolin (IC50 =0.012jum).
Discussion
In the present study, 3000 microorganisms (bacteria and fungi) were screened for their ability to convert lactone form of mevinolin. Only one strain, A. coerulea IDR705 was active in transformation of mevinolin into 1 Whenkeeping at ambient temperature in MeOH-d4solution for a week, compound 3 was transformed quantitatively into 3b. XH, 13C, DEPT135, NOEdifference and heterocorrelation spectra of compound3b were measured by a Bruker AC-250 NMR spectrometer (see Tables 1 and 2 ). (3) is formed by hydration through an 4a,5-epoxy intermediate by a known mechanism. This compoundhas been described as a synthetic productX). Biological activities of the transformation products are comparable to that of mevinolin.
The above results suggest that microbial transformation is a useful tool to generate newproducts from mevinolin or from other related compounds,such as compactin, affording lead compoundsfor new drugs and further data for structure activity relationship in this type of compound. 
